ChrysCapital Acquires Majority Stake in Novartis India
- Published:
- First detected:
Insights by Echo AI
Private equity firm ChrysCapital has acquired a controlling 70.68% stake in Novartis India, the listed unit of Swiss drugmaker Novartis AG. The ₹1,446-crore deal follows a strategic review by Novartis AG and marks ChrysCapital's first majority-controlled investment in India's pharmaceutical sector.
Source coverage
Aggregated
4
records merged
X / Twitter
2
2 unique
Telegram
0
0 unique
RSS
2
1 unique
4 Sources
PE firm ChrysCapital acquires Swiss parent’s stake in Novartis India T...
ChrysCapital acquires controlling 70.68% stake in Novartis' India list...
Novartis India Ltd gets recast as ChrysCapital acquires Swiss parent’s...
Unlock Echo Intelligence
Move beyond the public feed. Monitor breaking stories across Telegram, X, and the web — with earlier visibility, clearer context, and complete control over your sources.
- Monitor Telegram, X, and web in one place
- Add any source, from niche channels to global outlets
- Build custom feeds around events, regions, entities, or keywords
- Merge duplicate coverage into one clear, source-transparent story
- Auto-translate summaries and full articles
- Search past coverage and use AI-powered editorial tools
